🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06837974
Starting soon Not applicable

AI-guided TIPS Procedure

NCT06837974 · tracked via the Priya Life Science China tracker
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Not applicable
Started
2025-07-01
Last updated
2025-02-20

Condition(s) studied

Portal Hypertension Related to Cirrhosis

Investigational drug(s) / intervention(s)

AI guided TIPSArtificially blinded TIPS

AI guided TIPS: The TIPS procedure will be conducted under the guidance of AI model which was constructed based on the pre-operation enhanced CT images and intra-operation DSA images.

Artificially blinded TIPS: The TIPS procedure will be conducted based on the experience of operators.

Study summary

The goal of this clinical trial is to learn if transjugular intrahepatic portosystemic shunt (TIPS)-guided AI model can guide TIPS procedure in adults better than conventional TIPS procedure (artificially blinded TIPS). TIPS surgical outcomes and intraoperative and postoperative complications will also be observed. The main questions it aims to answer are:

* Does the AI model lower the number of punctures, radiation dose, and complications of participants undergo TIPS?
* Does the AI model improve the efficacy of TIPS for participants?

Participants will:

* Take the TIPS by the guidance of the AI model or conventional manually blinded penetration (placebo)
* The number of punctures, the success rate of the procedure, the radiation dose, intraoperative complications and postoperative complications within 3 months will be recorded
* Intraoperative portal pressure gradient drop values, symptoms of ascites and rebleeding within 3 months after TIPS will be reported

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Participants who require transjugular intrahepatic portosystemic shunt (TIPS) and meet the clinical indications for the procedure. * Participants whose physical condition is suitable for TIPS. Exclusion Criteria: * Participants with a history of allergy or serious adverse reactions to iodine contrast media or other related drugs. * Participants are pregnant or breastfeeding. * Participants are unwilling or unable to sign informed consent.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Wuhan Union Hospital Wuhan Hubei
Wuhan Union Jinyinhu Hospital Wuhan Hubei
Wuhan Union West Hospital Wuhan Hubei

More Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06837974 on ClinicalTrials.gov ↗ ← All trials in China